Active Stocks
Thu Mar 28 2024 15:48:07
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ News / World/  Coronavirus update: Sanofi says vaccine question isn’t when, but how
BackBack

Coronavirus update: Sanofi says vaccine question isn’t when, but how

Sanofi is working with rival GlaxoSmithKline Plc to develop a vaccine against the new coronavirus
  • Sanofi has made proposals to major countries to address the manufacturing challenge
  • Two volunteers have received vaccine trial against the COVID-19 on Thursday as part of the first human trials in the UK. (AP)Premium
    Two volunteers have received vaccine trial against the COVID-19 on Thursday as part of the first human trials in the UK. (AP)

    The head of one of the world’s biggest vaccine companies says Europe needs to wake up to the challenge of manufacturing enough coronavirus shots to halt the pandemic.

    As others squabble over the timing and details of how to develop such a vaccine, Sanofi Chief Executive Officer Paul Hudson points further ahead to the continent’s ability to produce enough to meet demand.

    “There is less concern about finding a successful vaccine than there is about making the volumes needed," Hudson told reporters on Friday. “The biggest untold story in Europe right now is the one about the number of doses."

    Sanofi is working with rival GlaxoSmithKline Plc to develop a vaccine against the new coronavirus, racing against other pharma giants such as Johnson & Johnson as well as nimbler biotechs such as Moderna Inc. Most of them aim to deliver a shot sometime next year.

    The U.S. may be in a position to vaccinate first, according to Hudson, thanks to the Biomedical Advanced Research and Development Authority, a government agency that backs vaccine development. There’s no similar coordination in Europe.

    “We don’t want to get to next summer and not have enough vaccines for Europe," Hudson said.

    Sanofi has made proposals to major countries and the European Commission to address the manufacturing challenge, he said, without elaborating.

    The volumes of vaccines required to fight Covid-19 are beyond the reach of many smaller companies and partnerships, according to Hudson. Sanofi’s and Glaxo’s efforts combined, he said, are “the best shot Europe has."


    Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

    This story has been published from a wire agency feed without modifications to the text.

    Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
    More Less
    Published: 26 Apr 2020, 01:20 PM IST
    Next Story footLogo
    Recommended For You
    Switch to the Mint app for fast and personalized news - Get App